title: Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.
abstract: A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.
authors.affiliation: Lazzaro Spallanzani Hospital for Infectious Diseases, Rome, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Tocci
authors.forename: L
authors.initials: L
authors.lastname: Antonelli
authors.forename: E
authors.initials: E
authors.lastname: Boumis
authors.forename: M
authors.initials: M
authors.lastname: Colaiacomo
authors.forename: P
authors.initials: P
authors.lastname: Guarascio
authors.forename: C
authors.initials: C
authors.lastname: Struglia
authors.forename: G
authors.initials: G
authors.lastname: Tossini
authors.forename: G
authors.initials: G
authors.lastname: Visco
mesh_terms: D000293:Adolescent; D000328:Adult; D001706:Biopsy; D002908:Chronic Disease; D005260:Female; D003699:Hepatitis D / Q000628:therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use*; D008099:Liver / Q000473:pathology; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D016896:Treatment Outcome
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins